Use Of Patented Traditional Chinese Medicine Against Covid-19.

Use Of Patented Traditional Chinese Medicine Against Covid-19.

Show other versions (1)
Saved in:
Bibliographic Details
:
Zhai, Huaqiang.
TeilnehmendeR:
Wang, Yanping.
Yang, Yiheng.
Li, Xiaodong.
Shao, Yingjun.
Place / Publishing House:Singapore : : World Scientific Publishing Company,, 2021.
©2021.
Year of Publication:2021
Language:English
Physical Description:1 online resource (187 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
Table of Contents:
  • Intro
  • Contents
  • Preface
  • About the Editors-in-Chief
  • Editorial Board
  • Chapter 1 Understanding COVID-19
  • Section 1: Understanding of COVID-19 in Modern Medicine
  • I. Basic Facts
  • 1. Terminology
  • 2. Pathogenic characteristics
  • II. Epidemiological Characteristics
  • 1. Source of infection
  • 2. Transmission route
  • 3. Susceptible population
  • III. Clinical Features
  • 1. Clinical manifestations
  • 2. Auxiliary tests
  • 3. Diagnostic criteria
  • 3.1. Suspected cases
  • 3.2. Confirmed cases
  • 3.3. Standardized ICD code
  • 4. Clinical classification
  • 4.1. Mild cases
  • 4.2. Common cases
  • 4.3. Severe cases
  • 4.4. Critical cases
  • 5. Differential diagnosis
  • Section 2: Understanding COVID-19 in Traditional Chinese Medicine
  • I. Historical Review
  • II. Disease Name
  • III. Etiology and Pathogenesis
  • IV. Treatment by Stages
  • Chapter 2 Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia
  • I. Etiological Characteristics
  • II. Epidemiological Characteristics
  • 1. Source of infection
  • 2. Route of transmission
  • 3. Susceptible population
  • III. Pathological Changes
  • 1. Lungs
  • 2. Spleen, hilar lymph nodes, and bone marrow
  • 3. Heart and blood vessels
  • 4. Liver and gallbladder
  • 5. Kidneys
  • 6. Other organs
  • IV. Clinical Characteristics
  • 1. Clinical manifestations
  • 2. Laboratory tests
  • 2.1. General findings
  • 2.2. Pathogenic and serological findings
  • 3. Chest imaging
  • V. Case Definitions
  • 1. Suspected cases
  • 1.1. Epidemiological history
  • 1.2. Clinical manifestations
  • 2. Confirmed cases
  • VI. Clinical Classification
  • 1. Mild cases
  • 3. Severe adult cases meeting any of the following criteria
  • 4. Critical cases
  • VII. Early Clinical Warning Indicators of Severe and Critical Cases
  • 1. Adults
  • 2. Children
  • VIII. Differential Diagnosis
  • IX. Case Finding and Reporting.
  • X. Treatment
  • 1. Treatment venue determined by the severity of the disease
  • 2. General treatment
  • 3. Treatment of severe and critical cases
  • 3.1. Treatment principle
  • 3.2. Respiratory support
  • 3.3. Circulatory support
  • 3.4. Renal failure and renal replacement therapy
  • 3.5. Convalescent plasma treatment
  • 3.6. Blood purification treatment
  • 3.7. Immunotherapy
  • 3.8. Other therapeutic measures
  • 4. Traditional Chinese medicine treatment
  • 4.1. During medical observation
  • 4.2. During clinical treatment (confirmed cases)
  • XI. Discharge Criteria and After-Discharge Considerations
  • 1. Discharge criteria
  • 2. After-discharge considerations
  • XII. Patients Transportation Principles
  • XIII. Nosocomial Infection Prevention and Control
  • Chapter 3 Rational Use of Chinese Patent Medicine
  • Section 1: Guiding Principles for the Clinical Application of Chinese Patent Medicine
  • I. Safety of Chinese Patent Medicine
  • II. Basic Principles of Clinical Application of Chinese Patent Medicine
  • 1. Use medicines based on pattern diagnosis/syndrome differentiation
  • 2. Medication selection based on both disease and pattern diagnosis
  • 3. Selection of dosage form
  • 4. Determination of dosage
  • 5. Rational administration route
  • 6. The use of Chinese medicine injection should also follow the below principles
  • III. Principle for Combined Use
  • 1. Combined use of Chinese patent medicines
  • 2. Combined use of Chinese patent medicine and Western medicine
  • IV. Principles of Use of Chinese Patent Medicine for Pregnant Women
  • V. Principles for the Use of Chinese Patent Medicine Among Children
  • Section 2: Contraindications in the Use of Chinese Patent Medicine
  • I. Contraindicated Patterns/Syndromes
  • II. Contraindicated Combination (Incompatibility)
  • III. Contraindications During Pregnancy
  • IV. Contraindications in Diet.
  • Section 3: Adverse Reactions and Adverse Events of Chinese Patent Medicine
  • I. Factors Causing ADRs/ADEs of Chinese Patent Medicine
  • 1. Medicines
  • 1.1. The ingredients of traditional Chinese medicines
  • 1.2. Misuse and Misapplication
  • 1.3. Quality of medicinal substances
  • 1.4. Improper processing or manufacturing
  • 1.5. Non-standard package insert
  • 2. Patients
  • 2.1. Special populations
  • 2.2. Idiosyncrasy
  • 3. Clinical use
  • 3.1. Inaccurate pattern diagnosis
  • 3.2. Overdose and prolonged use
  • 3.3. Improper combination
  • II. Management of ADRs/ADEs of Chinese Patent Medicines
  • 1. Right medicines for the right pattern
  • 2. Knowing about the Chinese patent medicine before use
  • 3. Treatment in accordance with season, region, and patient
  • 4. Rational concomitant medications
  • 5. Proper dosage &amp
  • dosage forms
  • Chapter 4 Guidance on Rational Application of Chinese Patent Medicine during Medical Observation Period
  • Section 1: Huoxiang Zhengqi Capsule (see Table 3) (Pill, Water, Oral Liquid)
  • I. Drug-Drug Interactions Among Concomitant Medications
  • 1. Concomitant medications
  • 1.1. The "eighteen clashes" in the combined use of Chinese herbal medicine
  • 1.2. Combined use of Western medicines
  • 2. Recommendations
  • II. Pharmacological Action
  • 1. Antispasmodic and analgesic effects
  • 2. Immunity-enhancing effects
  • 3. Gastrointestinal regulating effects
  • 4. Anti-emetic effects
  • 5. Anti-inflammatory effects
  • 6. Antiviral effects
  • 7. Bacteriostatic effects
  • 8. Improving water, electrolyte, and metabolic disorders
  • 9. Tranquilizing effects
  • III. Pharmacist's Notes
  • Section 2: Jinhua Qinggan Granule (see Table 3)
  • I. Drug-Drug Interactions Among Concomitant Medications
  • 1. Concomitant medications
  • 1.1. The "eighteen clashes" in the combined use of Chinese herbal medicine.
  • 1.2. Combined use of Western medicines
  • 2. Recommendations
  • II. Pharmacological Action
  • 1. Antiviral effects
  • 2. Anti-inflammatory effects
  • 3. Immunity-enhancing effects
  • III. Pharmacist's Notes
  • Section 3: Lianhua Qingwen Capsule (Granule) (see Table 3)
  • I. Drug-Drug Interactions Among Concomitant Medications
  • 1. Issues in concomitant medications
  • 2. Recommendations
  • II. Pharmacological Action
  • 1. Antiviral effects
  • 2. Antibacterial effects
  • 3. Immune Regulatory effects
  • 4. Antipyretic and anti-inflammatory effects
  • 5. Other effects
  • III. Pharmacist's Notes
  • Section 4: Shufeng Jiedu Capsule (see Table 3)
  • I. Drug-Drug Interactions Among Concomitant Medications
  • II. Pharmacological Action
  • 1. Antiviral effects
  • 2. Antibacterial effect
  • 3. Antipyretic effect
  • 4. Anti-inflammatory and immunomodulatory effects
  • 5. Analgesic effect
  • III. Pharmacist's Notes
  • Chapter 5 Guidance on Rational Application of Chinese Patent Medicine during Clinical Treatment Period
  • Section 1: Xiyanping Injection (see Table 1)
  • I. Administration and Dosage
  • II. Drug-Drug Interactions Among Concomitant Medications
  • 1. Issues of concomitant medications
  • 2. Recommendations
  • III. Pharmacological Action
  • 1. Antiviral effects
  • 2. Antibacterial effects
  • 3. Antitussive effects
  • 4. Anti-inflammatory and antipyretic effects
  • 5. Immunity-enhancing effects
  • IV. Pharmacist's Notes
  • Section 2: Tanreqing Injection (see Table 1)
  • I. Administration and Dosage
  • II. Drug-Drug Interactions Among Concomitant Medications
  • 1. Issues in concomitant medications
  • 2. Recommendations
  • III. Pharmacological Action
  • 1. Antibacterial and antiviral effects
  • 2. Anti-inflammatory and antipyretic effects
  • 3. Antitussive effects
  • 4. Spasmolysis
  • 5. Immunity-enhancing effects
  • 6. Apoptosis-promoting effects.
  • IV. Pharmacist's Notes
  • Section 3: Xuebijing Injection (see Table 1)
  • I. Administration and Dosage
  • II. Drug-Drug Interactions Among Concomitant Medications
  • 1. Issues in mixed administration
  • 1.1 The "eighteen clashes" in the combined use of Chinese herbal medicine
  • 1.2 Combined use of Western medicines
  • 2. Recommendations
  • III. Pharmacological Action
  • 1. Improving blood coagulation
  • 2. Anti-endotoxin effects
  • 3. Phagocytosis-improving effects
  • 4. Anti-inflammatory effects
  • 5. Immune-regulating effects
  • 6. Protect and repair damaged organs
  • IV. Pharmacist's Notes
  • Section 4: Xingnaojing Injection (see Table 1)
  • I. Administration and Dosage
  • II. Drug-Drug Interactions Among Concomitant Medications
  • 1. Issues in concomitant medications
  • 2. Recommendations
  • III. Pharmacological Action
  • 1. Regulating central nervous system
  • 2. Brain protection
  • 3. Reducing brain edema
  • 4. Improving brain microcirculation
  • 5. Antiepileptic effects
  • 6. Anti-angina effects
  • IV. Pharmacist's Notes
  • Section 5: Reduning Injection (see Table 1)
  • I. Administration and Dosage
  • II. Mixed Administration
  • 1. Issues in concomitant medications
  • 2. Recommendations
  • III. Pharmacological Action
  • 1. Antipyretic effects
  • 2. Antiviral effects
  • 3. Antibacterial effects
  • 4. Anti-inflammatory effects
  • 5. Analgesic effects
  • 6. Immunity-enhancing effects
  • IV. Pharmacist's Notes
  • Section 6: Shengmai Injection (see Table 1)
  • I. Administration and Dosage
  • II. Drug-Drug Interactions Among Concomitant Medications
  • 1. Issues in concomitant medications
  • 1.1. The "eighteen clashes" and "nineteen incompatibilities" in the combined use of Chinese herbal medicine
  • 1.2. Combined use of Western medicines
  • 2. Recommendations
  • III. Pharmacological Action
  • 1. Immunity-enhancing effects.
  • 2. Protecting the heart muscle.

Similar Items